Abstract
The role of chemotherapy and radiotherapy in adjuvant management of optimally debulked endometrial cancer with extrauterine involvement is evolving. Recent studies have suggested an expanded role for chemotherapy and questioned the benefit of radiation therapy. Ongoing and planned clinical trials should provide clarification.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Chemotherapy, Adjuvant
-
Endometrial Neoplasms / drug therapy
-
Endometrial Neoplasms / pathology
-
Endometrial Neoplasms / radiotherapy
-
Endometrial Neoplasms / surgery*
-
Female
-
Humans
-
Radiotherapy, Adjuvant
-
Randomized Controlled Trials as Topic
-
Treatment Outcome